Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blackthorn Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11112
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses Integrated Functional Objective Research Measures (INFORM) platform to discover and develop targeted treatments for neurobehavioral disorders. The company partners with academic innovation centers to develop various drug targets and clinical populations. Blackthorn Therapeutics is headquartered in San Francisco, California, the US.

Blackthorn Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Blackthorn Therapeutics Raises Additional USD14 Million in Series A Financing 10
Blackthorn Therapeutics Raises USD40 Million in Series A Financing 11
Partnerships 12
BlackThorn Therapeutics Enters into Agreement with Mindstrong Health 12
Licensing Agreements 13
BlackThorn Therapeutics Enters into Licensing Agreement with Yale University 13
Blackthorn Therapeutics Enters into Licensing Agreement with Eli Lilly 14
Equity Offering 15
Blackthorn Therapeutics Spin Off from Scripps Research Institute 15
Blackthorn Therapeutics Inc – Key Competitors 16
Blackthorn Therapeutics Inc – Key Employees 17
Blackthorn Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Nov 05, 2018: BlackThorn Therapeutics names Bill Martin, Ph.D., President and Chief Operating Officer 19
Jun 12, 2018: BlackThorn Therapeutics Names George S. Golumbeski, Ph.D., to Board of Directors 20
Aug 01, 2017: BlackThorn Therapeutics Names Matthew K. Fust to Board of Directors 21
Feb 07, 2017: BlackThorn Therapeutics Names Biotech Industry Veteran Gregory Vontz as Chief Executive Officer 22
Government and Public Interest 23
Jun 20, 2017: BlackThorn Therapeutics to Receive Up to $8 Million in NIH Blueprint Neurotherapeutics Network Funding to Advance Kappa Opioid Receptor Antagonist Program 23
Product News 24
04/06/2017: BlackThorn Therapeutics Provides Update on KOR antagonist pipeline program BTRX-395750 24
Clinical Trials 25
Dec 07, 2017: BlackThorn Therapeutics Presents Preclinical and Clinical Data from Its First-in-Class NOPR Antagonist at American College of Neuropsychopharmacology Annual Meeting 25
Jul 24, 2017: BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder 26
Apr 06, 2017: BlackThorn Therapeutics Announces Results of Preclinical Study of BTRX-335140, Demonstrating Therapeutic Potential in Modulating Brain Circuits Commonly Dysregulated in Neurobehavioral Disorders 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blackthorn Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blackthorn Therapeutics Raises Additional USD14 Million in Series A Financing 10
Blackthorn Therapeutics Raises USD40 Million in Series A Financing 11
BlackThorn Therapeutics Enters into Agreement with Mindstrong Health 12
BlackThorn Therapeutics Enters into Licensing Agreement with Yale University 13
Blackthorn Therapeutics Enters into Licensing Agreement with Eli Lilly 14
Blackthorn Therapeutics Spin Off from Scripps Research Institute 15
Blackthorn Therapeutics Inc, Key Competitors 16
Blackthorn Therapeutics Inc, Key Employees 17

List of Figures
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blackthorn Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Alinma Bank:企業の戦略・SWOT・財務分析
    Alinma Bank - Strategy, SWOT and Corporate Finance Report Summary Alinma Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • HCR ManorCare Inc:企業の戦略・SWOT・財務情報
    HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report Summary HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Epcor Utilities Inc:企業の戦略的SWOT分析
    Epcor Utilities Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • AC Immune SA (ACIU):企業の財務・戦略的SWOT分析
    AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • InSightec Ltd:企業の製品パイプライン分析2018
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • Terna SpA (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Terna S.p.A. (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers spec …
  • Booking Holdings Inc.:企業のM&A・事業提携・投資動向
    Booking Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Booking Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Asahi Intecc Co Ltd (7747):企業の財務・戦略的SWOT分析
    Summary Asahi Intecc Co Ltd (Asahi) is a medical device company that develops, manufactures and markets terminal processed products. The company provides medical components such as guide wires, balloon catheters, guiding catheters, penetration catheters, peripheral guide wires, IVR guide wires and m …
  • Gas2Grid Ltd (GGX):石油・ガス:M&Aディール及び事業提携情報
    Summary Gas2Grid Ltd (Gas2Grid) is an oil and gas company that offers exploration and development of conventional oil and gas onshore Cebu Island in the Philippines, Aquitaine Basin in south-west France and the Canning Basin, Australia. The company explores and develops conventional oil and gas, coa …
  • GS Energy Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary GS Energy Corp (GS Energy) is an energy holding company that manufactures and markets transportation fuels. The company's services include exploration and production, green growth, gas and electric power, refining and petrochemicals. It's refining and petrochemicals services comprise manufac …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Veloxis Pharmaceuticals AS (VELO)-製薬・医療分野:企業M&A・提携分析
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company, which develops therapies for kidney transplantation based on its proprietary MeltDose platform. MeltDose is a drug delivery technology, used to enhance oral bioavailability and control release of a drug. The company …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Adani Enterprises Ltd (ADANIENT):企業の財務・戦略的SWOT分析
    Adani Enterprises Ltd (ADANIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • Ingram Entertainment Inc.:戦略・SWOT・企業財務分析
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆